Myeloproliferative Neoplasms
Myeloproliferative Neoplasms (MPNs) are a group of rare blood cancers characterized by the overproduction of blood cells in the bone marrow, which can lead to various symptoms and complications.
Myelofibrosis and Essential Thrombocythemia: INCA033989 Study
We are evaluating the effects and safety of a new treatment called INCA033989 for individuals with myelofibrosis or essential thrombocythemia. This study aims to understand how well it works compared to current options.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Zealand University Hospital
Department of Hematology
Roskilde, Denmark
Lillebaelt Hospital
Department of Hematology
Vejle, Denmark
Institut Bergonie
Hematology department
Bordeaux, France
Sponsor: Incyte Corp.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.